Skip to main content
. 2022 Dec 2;18(11):e940–e948. doi: 10.4244/EIJ-D-21-01098

Table 1. Baseline and procedural characteristics.

Patient characteristics Clinical cohort (N=1,406 patients) (N=1,774 lesions)
Age (years) 68.6±10.1
Male 67.8% (953/1,406)
Obesity (BMI ≥30 kg/m²) 20.5% (285/1,391)
Hypertension 83.4% (1,169/1,401)
Hyperlipidaemia 70.5% (960/1,362)
Diabetes mellitus 39.9% (560/1,402)
Insulin-dependent diabetes mellitus 17.8% (249/1,402)
Coronary artery disease 40.5% (540/1,332)
Carotid artery disease 20.2% (241/1,196)
Current smoker 31.8% (447/1,406)
Renal insufficiency* 11.2% (136/1,216)
On dialysis 2.7% (38/1,396)
Previous peripheral revascularisation 52.4% (737/1,406)
Rutherford clinical category 1 0.1% (1/1,403)
2 31.1% (436/1,403)
3 57.7% (810/1,403)
4 8.6% (120/1,403)
5 2.6% (36/1,403)
ABI (mmHg ratio) 0.7±0.2
Lesion characteristics
Lesion length (cm) 12.1±9.5
Diameter stenosis (%) 88.8±12.3
Occluded 35.5% (630/1,774)
Lesion type De novo 74.3% (1,318/1,774)
Restenotic (non-stented) 7.7% (136/1,774)
In-stent restenosis 18.0% (320/1,774)
Reference vessel diameter (mm) 5.2±0.7
Calcification 68.7% (1,217/1,772)
Severe 10.2% (181/1,772)
Lesion location Superficial femoral artery 87.6% (1,554/1,774)
Proximal popliteal artery 27.3% (484/1,774)
Procedural characteristics
Predilatation 78.0% (1,097/1,406)
Post-dilatation 35.1% (491/1,397)
Provisional stenting 21.2% (373/1,762)
Dissections 0 56.7% (1,006/1,773)
A-C 35.4% (628/1,773)
D-F 7.8% (139/1,773)
Data are % (n/N) or mean±standard deviation. *Baseline serum creatinine ≥1.5 mg/dl. Protocol deviations, patients enrolled and included in analyses. Multiple lesion locations are reported in a single target limb, the total lesion locations could be more than the total number of target limbs. ABI: ankle-brachial index; BMI: body mass index